Full-Time

Director – Congress Innovation

Operations and Capabilities

Posted on 7/7/2025

Deadline 8/1/25
Bristol Myers Squibb

Bristol Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Compensation Overview

$207.5k - $251.4k/yr

+ Incentive Cash + Stock Opportunities

Company Historically Provides H1B Sponsorship

Summit, NJ, USA + 1 more

More locations: Princeton, NJ, USA

Hybrid

Hybrid work model with at least 50% onsite presence required.

Category
🩺Medical, Clinical & Veterinary (1)
Requirements
  • Minimum of relevant 10+ years of relevant pharmaceutical industry experience and 5+ years in the Congress Strategy and Operations roles.
  • Proven experience in congress management, leading events management teams, and external suppliers.
  • Demonstrated innovative mindset and implemented creative solutions that simplify processes and improve end-user experience.
  • Mentorship and coaching experience, building a foundation for leadership skills.
  • Excellent organizational and time management skills, with a keen sense of urgency and effective stress management.
  • Demonstrated ability to work effectively across a cross-functional internal and external matrix, while building relationships and maintaining a positive rapport with internal stakeholders, vendors, and suppliers.
  • Advanced project management skills, including budget creation, management, and reconciliation, knowledge of logistical aspects, and attendee management solutions for all event types.
  • Ability to lead through change and innovation, aligning with organizational goals.
  • Effective team leadership and development of direct reports.
  • Significant experience in supplier engagement and managing relationships with suppliers and service providers to deliver customer-focused services.
  • Demonstrated proficiency in effectively communicating and presenting to diverse global audiences and executive leadership teams.
  • Knowledge of the pharmaceutical congress industry, codes, and practices.
  • Proven change agility/resiliency, and ability to successfully engage internal and external stakeholders along a change journey.
  • International experience and ability and willingness to travel nationally/internationally (~20% based on requirements).
  • Strong analytical and problem-solving skills.
  • Ability to work under pressure and meet tight deadlines. Awareness of timely task completion.
  • Proficiency in digital tools and technologies relevant to congress operations.
  • Experience in content creation for congress booths and familiarity with platforms like Veeva for content management.
Responsibilities
  • Enhance innovation through new and alternative ways of approaching congress management and seek opportunities to simplify and automate processes.
  • Collaborate with Therapeutic Area Directors of Congress Excellence to monitor processes and follow up on feedback from stakeholders regarding congress innovation and operations for continuous improvement.
  • Ensure the implementation of congress management tools to facilitate informed decision-making and enhance operational efficiency.
  • Oversee the Congress Excellence Team's innovation, operations, capabilities, service standards, content development, productivity, compliance, and training for new congress roles.
  • Develop and implement strategies to enhance stakeholder engagement and satisfaction.
  • Offer strategic oversight by developing and maintaining analytical dashboards.
  • Partner with finance to realize full budget oversight and management.
  • Ensure end-to-end audit readiness.
  • Effectively support the implementation of new congress capabilities (e.g., scheduler for meetings, congress app, exhibit force).
  • Manage suppliers (Cvent, logistic agencies, exhibit agencies, etc.) and act as the point of contact (POC) for procurement.
  • Conduct regular process review to ensure adherence and alignment to processes in line with MSA/SLAs, playbook, and communication of BMS policy changes.
  • Lead operational planning, including completion and maintenance of the congress playbook, ongoing development of SOPs, and documenting best practices. Update policies, procedures, and resources.
  • Establish innovation, guiding principles, templates, processes, tools, and operating procedures to ensure consistent delivery and alignment of standards across therapeutic areas worldwide.
  • Create a high-performing and focused team that emphasizes teamwork, collaboration, customer focus, personal accountability, and a commitment to results.
  • Continually improve and harmonize the congress innovation and planning process across therapeutic areas.
  • Drive the adoption of digital tools and technologies to enhance congress operations and capabilities.
  • Ensure compliance with all relevant regulations, codes, and industry best practices.
  • Responsible to support the creation of an overarching booth story by integrating various elements and ensuring that the content aligns with the strategic objectives of the therapeutic area.
  • Work closely with agencies to concept and storyboard the booth story and collaborate with stakeholders such as WW and US Medical Affairs, Congress Management Team, and Corporate Branding team to ensure cohesion and alignment with strategic goals.
  • Utilize platforms such as Veeva for content creation, management, and distribution to ensure consistency and compliance.
  • Coordinate strategic input gathering and engage with internal teams including Portfolio Strategy, Early Assets group, and franchise leads to align on booth communication objectives and prioritize assets for congress content.

Bristol Myers Squibb (BMS) develops and delivers medicines for serious diseases, focusing on oncology, immunology, and cardiovascular conditions. The company invests heavily in research and development to create new drugs, which are sold to hospitals and patients after receiving regulatory approval. BMS also produces generic drugs, making healthcare more affordable while ensuring quality and safety. Committed to sustainability, BMS aims to improve patient outcomes and support the development of biosimilars.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • Chris Shibutani's appointment may drive strategic growth and innovation at BMS.
  • Advancements in targeted protein degradation enhance therapeutic offerings in oncology.
  • Partnership with BioNTech could provide a competitive edge against Merck's Keytruda.

What critics are saying

  • Antitrust litigation over Pomalyst could impact BMS's market position in oncology.
  • Reliance on real-world data presents challenges in data quality and implementation.
  • High costs and technical challenges in space research could affect treatment feasibility.

What makes Bristol Myers Squibb unique

  • BMS collaborates with BioNTech for next-gen cancer immunotherapy, enhancing oncology portfolio.
  • Focus on real-world data strategies could lead to faster drug market entry.
  • Developing bone disease treatments in space positions BMS as a leader in innovative research.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Company News

ISS National Lab
Jul 7th, 2025
This is Not the Time to Cut Space-enabled Medical Research

Bristol-Myers Squibb is developing novel bone disease treatments in space, and the National Stem Cell Foundation is studying 3D brain organoids derived from patients with Parkinson's disease in microgravity to observe disease progression more rapidly with the aim of identifying potential biomarkers for early diagnosis and therapeutic targets.

The Pharma Letter
Jun 26th, 2025
Bristol Myers faces new antitrust suit over multiple myeloma drug Pomalyst

Bristol Myers faces new antitrust suit over multiple myeloma drug Pomalyst.

Unlearn
Jun 24th, 2025
The Best 15 Minutes You'll Spend on Clinical Trials Today

At the 2025 "Digital Breakthrough for Pharma" Summit hosted by Bristol Myers Squibb, Unlearn's co-founder and machine learning scientist, Aaron Smith, took the stage to explain exactly how that vision is now a reality.

ROI-NJ
Jun 13th, 2025
Bristol Myers Squibb Names Shibutani As Evp, Chief Strategy Officer

Bristol Myers Squibb (BMS) this week appointed Chris Shibutani as executive vice president, chief strategy officer, effective immediately. Shibutani’s role is a new position on the BMS leadership team. The announcement was made on a LinkedIn post.Shibutani will lead the development and advancement of the company’s long-term strategic plan, collaborating across the enterprise to drive innovation and growth. He brings more than 25 years of experience in the financial services industry covering global pharmaceutical, biotechnology and medical device industries.Prior to BMS, Shibutani served as managing director in the global investment research division at Goldman Sachs. Previous roles include senior analyst positions at Hambrecht & Quist, Cowen, UBS, and J.P. Morgan.Before his career in finance, Shibutani was a physician trained in anesthesiology and critical care medicine at Massachusetts General Hospital and practiced at Memorial Sloan Kettering Cancer Center

PharmaData
Jun 13th, 2025
Bristol Myers Squibb Highlights Targeted Protein Degradation Data, Including CELMoD Agents, at EHA 2025

Bristol Myers Squibb highlights targeted protein degradation advances, including CELMoD agents and BCL6 Ligand-Directed Degrader, at EHA 2025 in Milan, Italy.

INACTIVE